The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cells.

Saved in:
Bibliographic Details
Title: The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cells.
Authors: Deserti M; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Sabbioni S; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Poli F; Pathology Unit, Azienda Unità Sanitaria Locale (AUSL) of Imola, Imola, Italy., Vasuri F; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Pathology Unit, Santa Maria delle Croci Ravenna Hospital, Ravenna, Italy., Relli V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Palloni A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Deiana C; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Brandi G; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Tavolari S; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Source: Frontiers in oncology [Front Oncol] 2026 Mar 02; Vol. 16, pp. 1713273. Date of Electronic Publication: 2026 Mar 02 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2026.1713273